A new case report was published in Volume 16 of Oncotarget on February 5, 2025, titled "Acquired RUFY1-RET rearrangement as a mechanism of resistance to lorlatinib in a patient with CD74-ROS1 ...

Here we present a case of a patient with stage IV CD-74-ROS1 fusion NSCLC discovered initially with RNA next generation sequencing (NGS) who acquired ...

On January 7, 2025, the FDA granted priority review to the new drug application for sunvozertinib (DZD9008), an oral EGFR ...

Hong Kong-listed Shanghai Henlius Biotech Inc, a subsidiary of Fosun Pharma, announced on Wednesday that its anti-PD-1 mAb, ...

Molecular profiling and genetic testing have revolutionised lung cancer treatment, says a doctor. They have enabled targeted therapies that are more effective and tolerable than traditional ...

Ariceum Therapeutics, a private biotech company based in Berlin, has announced that the US Food and Drug Administration (FDA) ...

Ac-satoreotide is a first-in-class Actinium-labelled somatostatin receptor 2 antagonist targeting extensive-stage Small Cell Lung Cancer or Merkel Cell ...

Guyana has made significant strides in the fight against cancer, with notable advancements in prevention, diagnosis, treatment, and patient care. The increase ...

The Pardes actress shocked fans in 2022 when Anupam Kher revealed her breast cancer diagnosis. After undergoing chemotherapy and multiple treatments, Mahima successfully defeated cancer. She has since ...

The new “lungs in a fridge” tech can keep the lungs intact for up to 18 hours, compared to about four hours when kept on it.

FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.

The NAACP is urging cancer be declared as a public health crisis in the Black community in response to troubling CDC research.